Results 41 to 50 of about 172,649 (313)

Clinical characteristics of cohorts delineated by serology result.

open access: yes, 2023
Clinical characteristics of cohorts delineated by serology result.
Victoria P. Sanderson (17357387)   +6 more
core   +1 more source

Comprehensive, Comparative Evaluation of 35 Manual SARS-CoV-2 Serological Assays

open access: yesMicrobiology Spectrum, 2023
The onset of the coronavirus disease 2019 (COVID-19) pandemic resulted in hundreds of in vitro diagnostic devices (IVDs) coming to market, facilitated by regulatory authorities allowing “emergency use” without a comprehensive evaluation of performance ...
Wayne Dimech   +5 more
doaj   +1 more source

Serology of paracoccidioidomycosis [PDF]

open access: yesMycopathologia, 2008
This review provides the background for understanding the role of a battery of diagnostic methods in paracoccidioidomycosis (PCM). This systemic mycosis is a disease endemic in many regions of Latin America, with sporadic cases also occurring throughout the world (mycosis of importation).
openaire   +2 more sources

Results of the 2007 INSTAND proficiency testing trial for bacteriologic infection serology: a summary report

open access: yes, 2010
Participation in external quality assessment schemes (EQUAS) is gaining increasing importance for quality control and surveillance of medical laboratories.
Coste, O   +4 more
core   +1 more source

Distributions of DENV pGOLD serology results by disease severity.

open access: yes, 2023
Distributions of DENV pGOLD serology results by disease severity.
Fátima Cardozo (14684814)   +14 more
core   +1 more source

Evaluation of the Potential Diagnostic Utility of the Determination of Selected Caspases—Markers Involved in the Regulation of Apoptosis—In Patients with Ovarian Cancer

open access: yesDiagnostics, 2021
Ovarian cancer remains a major diagnostic and therapeutic problem in modern gynecological oncology. For this reason, research which focuses on the search for new diagnostic markers and the assessment of their possible usefulness in clinical practice is ...
Aleksandra Mielczarek-Palacz   +2 more
doaj   +1 more source

HBV serology results.

open access: yes, 2018
HBV serology results.
Rachael M. Burke (5620841)   +10 more
core   +1 more source

SARS-CoV-2 serology and COVID-19 symptoms.

open access: yes, 2021
SARS-CoV-2 serology and COVID-19 symptoms.
Beesan Maraqa (9938561)   +7 more
core   +1 more source

Comprehensive, comparative evaluation of 25 automated SARS-CoV-2 serology assays

open access: yesMicrobiology Spectrum
The onset of the COVID-19 pandemic resulted in hundreds of in vitro devices coming to market, facilitated by regulatory authorities allowing “Emergency Use,” without a prior comprehensive evaluation of performance.
Wayne Dimech   +2 more
doaj   +1 more source

Changes in the Concentration of Markers Participating in the Regulation of the Apoptosis Receptor Pathway Involving Soluble Tumour Necrosis Factor Ligand inducing Apoptosis (sTRAIL) and Osteoprotegerin (OPG) in the Serum of Women with Ovarian Cancer—Participation in Pathogenesis or a Possible Clinical Use?

open access: yesCells, 2020
Due to the ability to selectively induce apoptosis in cancer cells, the most interesting target for clinical research is the tumour necrosis factor ligand inducing apoptosis (TRAIL), which binds specific receptors, including osteoprotegerin (OPG).
Aleksandra Mielczarek-Palacz   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy